Enzymatic wound debriding compositions with enhanced enzymatic activity
A technology of composition and enzymatic activity, which can be used in pharmaceutical combinations, medical preparations without active ingredients, and medical preparations containing active ingredients, etc., and can solve problems such as blocking proteolytic enzymes
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0139] The following examples serve to demonstrate certain non-limiting aspects of the invention. It should be appreciated by those of skill in the art that the techniques disclosed in the examples which follow represent techniques discovered by the applicant to function adequately in the practice of the invention. However, in light of the present invention, those skilled in the art will understand that many changes can be made in the disclosed embodiments without departing from the spirit and scope of the invention and still obtain the same or similar results.
example 1
[0140] Example 1: Dispersion of Collagenase / PEG 400 in Vaseline
[0141] The dispersions in Table 1 were prepared from different concentrations of polyethylene glycol 400 (PEG-400) dispersed in petrolatum.
[0142] Table 1
[0143]
[0144] *PEG-1450 was added to PEG-400 to form a semi-solid, yielding about 96% and 100% of total PEG, respectively.
[0145] The enzymatic debridement activity of each dispersion was determined by the above-mentioned in vitro artificial eschar model, and the results were obtained in figure 1 drawn in. as from figure 1 From the results it can be seen that the optimal amount of PEG-400 is about 20% w / w PET-400 based on the 24 hour curve.
example 2
[0146] Example 2: Dispersion of Collagenase / PEG 600 in Vaseline
[0147] The dispersions in Table 2 were prepared from different concentrations of polyethylene glycol 600 (PEG-600) dispersed in petrolatum.
[0148] Table 2
[0149]
[0150] The enzymatic debridement activity of each dispersion was determined by the in vitro artificial eschar model described above. result in figure 2 drawn in. as from figure 2 From the results it can be seen that the optimal amount of PEG-600 is about 30% w / w PEG-600 based on the 24 hour curve.
PUM
![No PUM](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/noPUMSmall.5c5f49c7.png)
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com